Is heritable genome editing compatible with equality in an inclusive society?
By Scottish Council on Human Bioethics,
Science Animated
| 07. 15. 2022
Heritable genome editing is being increasingly viewed as socially and morally acceptable so long as certain criteria are met. However, even despite these criteria, heritable genome editing may be in conflict with a progressive and inclusive society where all persons are considered equal. In this short animation, the Scottish Council on Human Bioethics presents philosophical arguments explaining why heritable genome editing may be at odds with equality in an inclusive society.
Watch the video here.
Additional Information: https://www.schb.org.uk/
Articles
Calum MacKellar. (2019) Genome Modifying Reproductive Procedures and their Effects on Numerical Identity, The New Bioethics 25:2, pages 121-136: https://www.tandfonline.com/doi/full/10.1080/20502877.2019.1606150
Calum MacKellar. (2021) Why human germline genome editing is incompatible with equality in an inclusive society. The New Bioethics 27:1, pages 19-29: https://www.tandfonline.com/doi/full/10.1080/20502877.2020.1869467
Robert Sparrow. (2019) Human Germline Genome Editing: On the Nature of Our Reasons to Genome Edit, Published online: 19 Apr 2021, The American Journal of Bioethics: https://www.tandfonline.com/doi/full/10.1080/15265161.2021.1907480
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...